Artificial Blood: Global Markets to 2028

Report Code: BIO164B

Publish Date: Sep 2023

Publisher: BCC Publishing

Category: Cell Biology

Download Report Overview

CUSTOMIZE NOW

Explore Our Services

Already a member? Login to access this report free.

Report Highlights

The global artificial blood market reached $23.9 million in 2022, should reach $26.1 million by 2023 and $40.5 million by 2028 with a compound annual growth rate (CAGR) of 9.2% during the forecast period of 2023-2028.

Report Includes

  • 41 tables
  • An overview of the global markets for artificial blood
  • Estimation of market size and analyses of global market trends, with data from 2020-2022, estimates for 2023, and projections of compound annual growth rates (CAGRs) through 2028
  • Highlights of the market potential and characterization of artificial blood market by product, application, and region
  • Examination of the key drivers and constraints that will shape the market and discussion on the upcoming market opportunities and areas of focus to forecast the market into various segments and sub-segments
  • Coverage of recent advances, emerging technologies, and developments of the industry
  • Evaluation of key industry acquisitions and strategic alliances and market share analysis of the leading suppliers of the industry
  • Company profiles of major players within the industry, including Hemarina, VirTechBio, and NuvOx Pharma

Report Scope

The scope of this study encompasses an investigation of the global market for artificial blood, focusing on various important aspects of the market, such as research and development, clinical trial outcomes, approval status, and the potential commercial demand for artificial blood products. The report includes a discussion of artificial oxygen carrier products. BCC Research analyzes each market segment and provides a forecast for six years. The current report analyzes the market's drivers, challenges, and opportunities. The report also covers market projections for 2028 and the market analysis for key market players. The report includes the company profiles of the key players with detailed information about their business segments, financials, product portfolios, and recent developments. The report also provides information on emerging technologies, the impact of COVID-19, product analysis, deals, and investment outlook.

Report Synopsis

Report Metrics Details
Base year considered 2022
Forecast period considered 2023-2028
Base year market size $23.9 million
Market size forecast $40.5 million
Growth rate CAGR of 9.2% for the forecast period of 2023-2028
Units considered $ Millions
Segments covered Source, Type
Regions covered North America, Europe, Emerging markets
Key Market Drivers
  • Increasing Demand for Blood Transfusions
  • Risks and Challenges Associated with Blood Transfusions
  • Shortage of Blood Supply
Companies studied
AURUM BIOSCIENCESERYPHARM
HEMOGLOBIN OXYGEN THERAPEUTICS LLC.HEMARINA
KALOCYTE INC.NANO SANGUIS S.A
NUVOX PHARMA LLC.PROLONG PHARMACEUTICALS LLC.
RED C BIOTECHVIRTECH BIO
Need pricing for multiple titles, a complete report bundle, or something specially curated to fit your budget? EXPLORE OFFERS

Frequently Asked Questions (FAQs)

The artificial blood market is estimated to be $23.9 million in 2022 and is forecasted to grow at a CAGR of 9.2% to reach a value of $40.5 million in 2028.
The key factors contributing to the growth of the market include increasing demand for blood transfusions, risks and challenges associated with blood transfusions and shortage of blood supply.
In this report, the current market and the potential market is estimated.
Currently only one product is approved in the market, which is in Europe. However, in future, North America is expected to have the highest share followed by Europe and emerging markets. It is observed that majority of the startup companies are based in U.S and European regions and conducting trials in the base locations.
Key companies in the market include Hemarina, VirTechBio and NuvOx Pharma.

Analyst Credentials

BCC Research Team possesses expertise and experience in life and physical science domains. They specialize in offering valuable business insights, including industry analysis, competitor intelligence, strategic and financial analysis, and opportunity assessment. The team has in-depth knowledge of various sectors, including healthcare, biotechnology, pharmaceuticals, IT, automation, advanced materials, and energy. They are proficient in qualitative and quantitative market intelligence providing clients with actionable insights. With a vast understanding of the competitive landscape, the team can support clients in making data-driven decisions to help them achieve a competitive edge in their respective markets.

Let us assist you! Our analysts are ready to tailor this report to your specific need. Talk to Our Analyst

Table of Contents

All reports provided in PDF format. For shared licensing options (5+ Users), please call a representative at (+1) 781-489-7301 or contact us at info@bccresearch.com
Title/Chapter NamePagesMember Price
Full Report: Artificial Blood: Global Markets to 2028120Free
Chapter- 1: Introduction4Free
Chapter- 2: Summary and Highlights3Free
Chapter- 3: Market Overview12Free
Chapter- 4: Market Dynamics8Free
Chapter- 5: Artificial Blood by Source10Free
Chapter- 6: Artificial Blood by Type16Free
Chapter- 7: Market Estimation8Free
Chapter- 8: Emerging Technologies and Developments5Free
Chapter- 9: Product Analysis36Free
Chapter- 10: Patent Analysis5Free
Chapter- 11: Competitive Intelligence3Free
Chapter- 12: Company Profiles10Free

Related Reports

Global Markets for Blood Plasma Products

Published - Mar 2023 | Publisher - BCC Publishing | Code - HLC201C

The global blood plasma products market should reach $45.7 billion by 2027 from $33.2 billion in 2022 at a compound annual growth rate (CAGR) of 6.6% for the forecast period of 2022 to 2027.

Global Blood Transfusion and Intravenous Equipment Market

Published - May 2022 | Publisher - BCC Publishing | Code - HLC244B

The global blood transfusion and intravenous equipment market is estimated to increase from $19.0 billion in 2021 to reach $25.3 billion by 2026, at a compound annual growth rate (CAGR) of 5.9% during the forecast period of 2021-2026.

Track the Latest Global Tariff Developments

In today's fast-paced global economy, tariffs are no longer static—they are dynamic levers shaped by geopolitical realignments, supply chain vulnerabilities, inflationary pressures, and sustainability-driven trade reforms. As governments worldwide recalibrate their trade strategies, businesses are left to navigate a maze of shifting rules, rising costs, and regulatory uncertainty.

Our analysis empowers you with real-time updates and in-depth expert analysis on all facets of global tariff activity. From new trade agreements and sanctions to abrupt tariff hikes and retaliatory duties, we monitor developments across borders, sectors, and industries—so you don't have to.

Whether it's the ongoing U.S.–China trade dynamics, the evolving EU Carbon Border Adjustment Mechanism (CBAM), or the emerging policies in India, ASEAN, and Latin America, we provide full-spectrum coverage. We also track multilateral trade negotiations, World Trade Organization (WTO) rulings, and sector-specific duty structures—ensuring you are always ahead of global trade shifts.

With our analysis, you can stay informed, identify risks, and confidently respond to tariff changes—no matter where you operate.

Ready to see what tariff means for your business?

Consult with our experts or request your custom Tariff Impact Brife today

Stay Informed, Stay Competitive

In today's interconnected and unpredictable global economy, staying ahead of tariff shifts is not just important—it's essential. BCC Research provides decision-makers with trusted, research-driven insights that turn uncertainty into opportunity.

Our in-depth market analysis and trade intelligence help you decode how tariff changes impact your specific sector—manufacturing, healthcare, technology, agriculture, or energy. We break down complex data into actionable knowledge through comprehensive reports, expert commentaries, and sector-focused forecasts.

Our analysis includes:

  • Thorough breakdowns of current and proposed tariff policies and how they affect regional and global trade flows.
  • Sector-specific implications, helping you understand the strategic impact on sourcing, pricing, and competitiveness.
  • Forward-looking insights to support risk management, planning, and response strategies for evolving trade conditions.

With BCC Research, you gain more than just information—you gain clarity and confidence to make well-informed decisions in a volatile trade environment.

Don't let tariffs catch you off guard—let our insights guide your strategy.

This is an Excel-only version of the report.

Report Includes

    Total Number of Tables in this Report: 42

  • Summary Table: Global Market for Artificial Blood, Through 2028
  • Table 1: Historical Events Related to Blood Transfusion, 1628-2022
  • Table 2: Potential Benefits and Application Areas of Artificial Blood
  • Table 3: Average Number of Blood Units Required During Particular Medical Conditions
  • Table 4: The Challenges Associated with the Development of Artificial Blood
  • Table 5: Common Challenges to the Blood Transfusion Continuum in LMICs.
  • Table 6: Sources of Hemoglobin Molecules Used to Prepare Free Hemoglobin Solutions
  • Table 7: Pros and Cons of Artificial Blood Developed from Human Blood
  • Table 8: Pros and Cons of Artificial Blood Developed from Animal Blood
  • Table 9: Pros and Cons of Artificial Blood Developed from Recombinant Blood
  • Table 10: Summary of Acellular Hb-Based Oxygen Carriers
Sample Report

Recent Reports

Global Biochip Markets: Microarrays and Lab-on-a-Chip

Published - Jun 2025 | Publisher - BCC Publishing | Code - BIO049G

The global market for biochip was valued at $16.1 billion in 2024 and is estimated to reach $27.8 billion by 2029, at a compound annual growth rate (CAGR) of 11.6% from 2024 through 2029.

Global Cell Line and Membrane Market

Published - Jun 2025 | Publisher - BCC Publishing | Code - BIO178B

The global market for cell lines and membranes was valued at $5.7 billion in 2024 and is estimated to increase from $6.3 billion in 2025 to reach $11.4 billion by 2030, at a compound annual growth rate (CAGR) of 12.5% from 2025 through 2030.

Human Microbiome-based Drugs and Diagnostics: Global Markets

Published - May 2025 | Publisher - BCC Publishing | Code - BIO151B

The global market for human microbiome-based drugs and diagnostics is expected to grow from $393.4 million in 2025 to reach $1.2 billion by the end of 2030, at a compound annual growth rate (CAGR) of 25.6% from 2025 through 2030.

Global Microbiome Sequencing Market

Published - May 2025 | Publisher - BCC Publishing | Code - BIO183B

The global microbiome sequencing market is expected to grow from $1.5 billion in 2024 and is projected to reach $3.7 billion by the end of 2029, at a compound annual growth rate (CAGR) of 19.3% during the forecast period of 2024 to 2029.

Proteomics: Technologies and Global Markets

Published - May 2025 | Publisher - BCC Publishing | Code - BIO034G

The global market for proteomic technologies was valued at $27.6 billion in 2024. It is projected to grow from $31.0 billion in 2025 to $57.2 billion by the end of 2030, at a compound annual growth rate (CAGR) of 13.0% from 2025 to 2030.

Top Trending Reports

Next-Generation Advanced Batteries: Global Markets

Published - May 2025 | Publisher - BCC Publishing | Code - FCB062B

The global market for next-generation advanced batteries is estimated to grow from $1.5 billion in 2024 to reach $5.3 billion by the end of 2029, at a compound annual growth rate (CAGR) of 28.5% from 2024 through 2029.

Global Pharmaceutical Drugs Industry: Competitive Landscape 2023

Published - May 2025 | Publisher - BCC Publishing | Code - PHM263B

This report discusses the global pharmaceutical drugs industry and its competitive landscape in terms of significant player market ranking and top pharmaceutical drugs. Company profiles of the top 50 pharmaceutical companies, innovative products and technologies, trends and market dynamics, competitive intelligence, and regional trends are well-researched and analyzed in this report.

Biologic Therapeutic Drugs: Technologies and Global Markets

Published - May 2025 | Publisher - BCC Publishing | Code - BIO079F

The global market for biologic therapeutic drugs is estimated to increase from $499.2 billion in 2024 to reach $794.5 billion by 2029, at a compound annual growth rate (CAGR) of 9.7% from 2024 through 2029.

Global Markets and Manufacturing Technologies for Protein Drugs

Published - Apr 2025 | Publisher - BCC Publishing | Code - BIO021G

The global protein drugs market is expected to grow from $441.7 billion in 2024 and is projected to reach $655.7 billion by the end of 2029, at a compound annual growth rate (CAGR) of 8.2% during the forecast period of 2024 to 2029.

2024 Medical Devices Research Review

Published - Mar 2025 | Publisher - BCC Publishing | Code - MDS060B

The medical device industry is a multi-billion-dollar industry whose outlook is supposed to rise in the coming years These devices treat and diagnose a multitude of patient conditions and work much better than drugs.

Published - Apr-2018| Analyst - BCC Publishing| Code - BIO164A

Report Highlights

The global market for potential artificial blood is estimated to grow from nearly $6.2 billion in 2022 to $15.6 billion by 2027 with a compound annual growth rate (CAGR) of 20.5% for the period of 2022-2027.

Report Includes

  • 144 tables
  • Country specific data and analysis for USA, Canada, Mexico, Germany, France, UK, Italy, Spain, Russia, China, Japan, India, Australia, Brazil, and South Africa
  • Identification of growth-driving factors influencing the artificial blood market, as well as opportunities, restraints, and technological developments
  • Profiles of leading companies in the market, including Alliance Pharmaceutical Corp., Baxter Healthcare Corp., Northfield Laboratories Inc., Sanguine Biosciences, and Therapure Biopharma Inc.

Become A Member

BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.

Find Out More

Custom Consulting

BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.

Customize Now

Scorecard

The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.

Find Out More

Innovation Spotlight

Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.

Find Out More
Artificial Blood: Global Markets to 2028
Sample Report